Meghmani Organics Q2 FY27 profit rises 193% to Rs 33.9 crore

Meghmani Organics Limited reported consolidated net profit of Rs 33.9 crore for Q2 FY27, up 193% year on year, while consolidated EBITDA increased 40% to Rs 73 crore. The earnings improvement came alongside revenue growth, although elevated raw-material, energy and logistics costs reduced profitability in key operating segments.

How did Meghmani Organics perform in Q2 FY27?

Meghmani Organics Limited, referred to as Meghmani Organics, reported consolidated revenue of nearly Rs 666 crore in the quarter ended September 30, 2026, a 16% increase from a year earlier. Consolidated EBITDA rose 40% year on year to Rs 73 crore, while the EBITDA margin improved to 11% from 9% in the corresponding quarter of the previous year.

Consolidated net profit increased 193% year on year to Rs 33.9 crore. For the first half of FY27, consolidated revenue was Rs 1,209 crore, up 2% year on year. Half-year net profit rose 239% to Rs 82.1 crore and EBITDA grew 44% to Rs 171 crore, with the EBITDA margin reaching 14.1%, compared with 10% a year earlier.

On a standalone basis, quarterly revenue was nearly Rs 658 crore, up 18% year on year. Standalone net profit increased 6% to Rs 45 crore, while EBITDA was broadly flat at Rs 70.9 crore. The difference between standalone and consolidated profit trends reflects the separate reporting bases disclosed by Meghmani Organics.

Why did Meghmani Organics' operating margins decline sequentially?

Meghmani Organics said its EBITDA margin declined to 10.1% in Q2 FY27 from 12.1% in Q1 FY27 because input and logistics costs rose sharply while end-product realisations remained broadly flat. Chairman and Managing Director Ankit Patel attributed the pressure to higher raw-material prices linked to crude oil and the Middle East conflict, as well as increased energy, coal and logistics expenses.

Management said the first quarter had benefited from low-cost inventory and some price pass-through amid supply concerns. As buyers assessed that supply from India and China remained stable, pricing pressure returned to manufacturers. This limited the company's ability to recover higher costs from customers during the second quarter.

The crop protection business was particularly affected. Its EBITDA margin declined to about 11% in Q2 from 19-20% in Q1, as raw-material prices remained volatile and cost increases could not be fully passed on. Meghmani Organics said it was focusing on product mix, operating efficiencies and profitability measures while the cost environment remained challenging.

What were the main segment trends for Meghmani Organics?

Crop protection accounted for about 75% of standalone Q2 revenue, with pigments contributing the remaining 25%. Crop protection production was nearly 10,000 metric tonnes, capacity utilisation was 72%, revenue was nearly Rs 496 crore and EBITDA was Rs 54 crore. The segment's reported EBITDA margin was about 11%.

Management expects the crop protection segment to deliver double-digit growth over the next two to three years and has indicated a long-term EBITDA-margin range of 15-17%. It also said the European market remained difficult because of high costs and demand conditions, while the company's agrochemical exposure to Europe was minimal because of regulatory risks.

The pigment segment produced 4,252 metric tonnes and operated at 51% capacity utilisation. It reported revenue of Rs 161 crore and EBITDA of Rs 16 crore, resulting in an EBITDA margin of about 10%. Meghmani Organics indicated that pigment profitability had improved and guided for a 10-11% margin, but it did not expect significant growth potential, with revenue guidance of Rs 600-650 crore.

Titanium dioxide operations remained suspended because high raw-material costs made them commercially unviable. Management highlighted sulfuric acid prices that had increased seven to eight times. The reimposition of anti-dumping duty on titanium dioxide imports from China for five years was described as a positive development for the titanium dioxide business.

What do the merger and balance-sheet details mean for investors?

Meghmani Organics has received National Company Law Tribunal approval to amalgamate its wholly owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, with the parent company. Management said the amalgamation would create a single unified legal entity and enable operational and financial synergies.

The company reported standalone debt-to-equity of 0.27 times and consolidated debt-to-equity of 0.41 times. It also disclosed debt repayment of Rs 64 crore. These figures indicate that the company has continued to reduce debt while pursuing the proposed organisational integration.

Working-capital conditions remain a point to monitor. Trade receivables had increased to more than 125 days from a normal range of 100-110 days, and management said near-term improvement would be difficult. Meghmani Organics has not announced a dividend for the past two to three years, citing its focus on cash flow; it said a future dividend would depend on market improvement.

How are crop nutrition and market conditions shaping the outlook?

Meghmani Organics said crop nutrition offers growth potential through new nano-fertiliser products. Management expects double-digit growth in the segment and has indicated an EBITDA-margin target of 20-22%. The company discussed the opportunity while acknowledging questions around negative reports concerning nano urea in India.

The quarterly results show a mixed operating picture. Revenue and consolidated profit increased, and the company has set segment-specific margin targets. But the immediate performance of crop protection and titanium dioxide remains exposed to raw-material, energy and freight costs, as well as the company's ability to recover those costs through selling prices.

For investors, the reported earnings should therefore be assessed with the divergence between year-on-year consolidated profit growth and sequential margin pressure in mind. The receivables cycle, crop protection margin recovery, pigment utilisation and the implementation of the subsidiary amalgamation are relevant operating markers disclosed by management.

Conclusion

Meghmani Organics delivered a substantial year-on-year increase in consolidated Q2 FY27 profit, with net profit reaching Rs 33.9 crore and EBITDA rising to Rs 73 crore. Revenue growth and improved pigment profitability supported the result, but higher input, energy and logistics costs reduced sequential margins, especially in crop protection.

The next developments to watch are progress in the amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, the company's ability to manage receivables above 125 days, and whether cost conditions allow recovery toward management's stated segment margin ranges. The five-year anti-dumping duty on Chinese titanium dioxide imports is also relevant while titanium dioxide operations remain suspended.